Large-no-BG

NOW PHARMAC FUNDED*

Find out more

*Herzuma is a fully funded medicine for patients with HER2 positive early breast cancer, HER2 positive metastatic breast cancer and HER2 positive advanced gastric or gastro-oesophageal junction cancer – restrictions apply.

THIS SITE IS DESIGNED FOR THE GENERAL PUBLIC IN NEW ZEALAND.

PRESCRIPTION MEDICINE. Herzuma (trastuzumab biosimilar) is a prescription-only medicine containing trastuzumab. Herzuma powder for intravenous infusion is available as: (i) Herzuma 150mg vial containing 150mg of trastuzumab and (ii) Herzuma 440mg vial containing 440mg of trastuzumab.

USES OF HERZUMA. Herzuma is prescribed for adult patients with HER2-positive: (i) early breast cancer, (ii) metastatic breast cancer, and/or (iii) metastatic gastric cancer.

RISKS AND BENEFITS. Herzuma has risks and benefits. Always discuss your condition and treatment plan with your healthcare professional to determine if Herzuma is right for you. If you have any specific questions about how Herzuma might affect your treatment, side effects, or interactions with other medications, please seek their advice.